Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience

BACKGROUND: The aim of the study is to evaluate the role of cytoreductive nephrectomy (CN) with thrombectomy before targeted molecular therapy (TMT) on survival in metastatic renal cell carcinoma (mRCC) with venous tumor thrombus. METHODS: We performed a retrospective analysis of 47 patients treated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Surg Oncol
Main Authors: Qi, Nienie, Wu, Pengjie, Chen, Jinchao, Li, Teng, Ning, Xianghui, Wang, Jin, Gong, Kan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217450/
https://ncbi.nlm.nih.gov/pubmed/28056988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-016-1066-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados